Medium materiality5/10
Haemonetics PT raised to $165 at Mizuho
Why it may matterVerify against the original reporting
Bullish analyst update with substantial target-implied upside and little reported price movement since the signal.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Mizuho raised its price target on HAE to $165 from a posted price of $124.07. The reported price change since the signal is negligible.
- Mizuho PT: $165 vs. posted price $124.07
Key facts
- 01
Target: $165
- 02
Posted price: $124.07
- 03
Analyst firm: Mizuho Securities
- 04
Analyst: Anthony Petrone
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.